Showing results (651-660 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|May 6, 2014
Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccinesA T Newall, M Jit, R HutubessyPharmacoeconomics|March 21, 2023
Comprehensive Review of Methods to Assess Uncertainty in Health Economic EvaluationsThomas Michael Otten, Sabine E Grimm, Bram Ramaekers, et al.Pharmacoeconomics|July 17, 2023
Conducting Trial-Based Economic Evaluations Using R: A TutorialÂngela Jornada Ben, Johanna M van Dongen, Mohamed El Alili, et al.Pharmacoeconomics|June 15, 2026
A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic EvaluationsKarl Vivoda, Harvey Koh, Tamrat Befekadu Abebe, et al.Pharmacoeconomics|May 21, 2008
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokersPaul Howard, Christopher Knight, Annabel Boler, et al.Pharmacoeconomics|December 22, 2016
A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar DisorderIfigeneia Mavranezouli, Joran LokkerbolPharmacoeconomics|November 1, 2016
A Review of US Drug Costs Relevant to Medicare, Medicaid, and Commercial Insurers Post-Affordable Care Act Enactment, 2010-2016Jacquelyn McRae, F Randy Vogenberg, Silky Webb Beaty, et al.Pharmacoeconomics|October 26, 2016
Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and TaxonomyAnthony J Hatswell, Nick Freemantle, Gianluca BaioPharmacoeconomics|October 28, 2016
Simulation Modelling in Ophthalmology: Application to Cost Effectiveness of Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration in the United KingdomLindsay Claxton, Robert Hodgson, Matthew Taylor, et al.Pageof 335